Diabetes

Insulin glargine-yfgn (Semglee; Viatris) presents the first opportunity for retail pharmacists to dispense a biosimilar to patients.

Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity (SHC), addresses how the diabetes DRIVE program compares with the SHC DRIVE models for flu and COVID-19 vaccinations.

Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity (SHC), addresses what the SHC’s diabetes DRIVE toolkit is and how it helps to address disparities in diabetes disease burden and health outcomes.

Despite demonstrating numerous benefits, semaglutide has also been linked to an increased incidence of diabetic retinopathy, which was initially reported in the SUSTAIN-6 trial.

TXNIP inhibition could prevent beta cell loss and protect beta cell function to potentially contribute to diabetes management and its complications.

The data highlight a new role for pregnancy-associated plasma protein A, known as PAPP-A, in gestational diabetes, with translational potential as both a diagnostic tool and therapeutic target, according to the investigators.

Prevalence of type 2 diabetes has been found higher in people with bipolar disorder, schizophrenia, and major depression compared to the general population.

Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity, addresses disparities occurring in diabetes care among racial and ethnic populations.

The new analysis includes approximately 1100 women without type 1 or type 2 diabetes (T2D) who subsequently gave birth at least once during the 25-year study period, which ended in 2011.

Pharmacists can help to reduce the prevalence of food insecurity and its negative health care outcomes by tailoring clinical care to each individual patient’s needs.

The investigators analyzed an existing data set from the Eunice Kennedy Shriver National Institute of Child Health and Human Development Fetal Growth Studies, which included surveys on diet and exercise from a diverse patient population at 12 hospital centers across the United States.

Glipizide stimulates beta cells to produce more insulin in the body.

A panel of experts discusses diabetes treatment management and the impact pharmacists can have on an increasingly diverse patient population.

A more customized approach could be beneficial in terms of reducing illness via lifestyle and medication intervention monitoring.

Admelog is indicated to improve glycemic control in type 1 and type 2 diabetes mellitus.

Galectin-1 may offer a protective function for the kidneys in patients with type 2 diabetes at high risk of diabetic nephropathy.

Almost 80% of individuals with type 2 diabetes lost more than 22 pounds and maintained that weight loss in remission for at least 2 years, study results show.

The primary goal for 2021 is for patients to become aware of their diabetes status and complete smaller healthy lifestyle changes to make a big difference in diabetes prevention and management.

Jet injection has been researched for years, including the development of jet injectors for insulin, nicotine, and local anesthetic for dental procedures

Individuals with diabetes and atrial fibrillation were less likely to notice symptoms of irregular heartbeat.

Synjardy is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

This weight loss can prevent the onset of type 2 diabetes for new mothers.

For patients with diabetes, continuous glucose monitoring offers the opportunity to lessen the burden of traditional finger sticks.

Opportunities are continuously expanding in screening and medication therapy management services.

By inhibiting SGLT2, dapagliflozin reduces reabsorption of filtered glucose.

Dulaglutide is a glucagon-like peptide-1 receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Having community pharmacists to influence outcomes associated with social determinants of health in the US population is vital to improving overall patient outcomes.

Aflibercept is indicated for the treatment of patients with neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, and diabetic retinopathy.

The biggest advantage of med sync for a community pharmacy is the proactive selection of a date to have all the patient’s chronic medications filled simultaneously.

Diabetic ketoacidosis develops when the body can't produce enough insulin.